| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faca0baca1a01851f6e22590d821cbf2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca8cb693984d7c8d176a81dc862706a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07eae1607567ca58b0bfe1ff8007cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_649590ee8179b1e34bf264c0cc2de086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc7d1e6beafc209b0b24c8a8b96c889 |
| publicationDate |
2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019165964-A1 |
| titleOfInvention |
Cyclobutane dicarboxylic acid platinum complex and intermediary, preparation method, pharmaceutical composition, and use thereof |
| abstract |
A cyclobutane dicarboxylic acid platinum complex shown in formula (I) and an intermediary, a preparation method, a pharmaceutical composition, and a use thereof. The cyclobutane dicarboxylic acid platinum complex has good anti-tumour activity. The complex provided in the present invention has a water solubility several dozen times higher than existing platinum anti-tumour drugs; the feature of high water solubility can increase and improve the excretion of drugs in the kidneys and alleviate the high renal toxicity side effects normally present for platinum drugs; the compounds are easily formulated and more convenient for clinical application. |
| priorityDate |
2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |